2017-2021 US Immunodiagnostics Market: Supplier Shares and Sales Forecasts by Test Category

February 2017 | 35 pages | ID: U47D55C3222EN
Venture Planning Group

Abstracts

This report provides an overview of the US immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays. Contains 35 pages and 5 tables

Contents

BUSINESS ENVIRONMENT

1. HEALTH CARE EXPENDITURES
2. COST CONSCIOUSNESS
3. INDUSTRY CONSOLIDATION
4. MANAGED CARE
5. HOSPITALS
6. ADMISSIONS
7. LENGTH OF STAY
8. INDUSTRY DIVERSIFICATION
9. PHYSICIAN DEMOGRAPHICS
10. POPULATION AGING
  A. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
11. LABORATORY REGULATIONS

MARKET STRUCTURE

1. CENTRALIZED TESTING
  A. Hospitals
  b. Commercial/Private Laboratories
2. DECENTRALIZED TESTING
  A. Physician Offices/Group Practices
  b. PointofCare Testing
  c. Home/Self Testing
  d. Other Decentralized Testing Locations
Market Size, Growth, Major Suppliers' Instrument and Reagent Sales and Market Shares

List Of Tables

LIST OF TABLES

Clinical Chemistry and Immunodiagnostic Volume Forecasts By Test Category
Clinical Chemistry and Immunodiagnostic Reagent Sales Forecasts By Test Category
Clinical Chemistry and Immunodiagnostic Instrument Sales Forecasts By Analyzer Type
Estimated Sales and Market Shares of Major Suppliers Of Clinical Chemistry Instruments and Reagents
Estimated Sales and Market Shares of Major Suppliers Of Immunodiagnostic Instruments and Reagents